Simplex Trading’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Simplex Trading’s Portfolio NGM Stock Details NGM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-28	Closed	–	–	10156
2024 Q1	$0	Sell	28 -119	-81%	-$177	﹤0.01%	10235
2023 Q4	$0	Sell	147 -208	-59%	-$183	﹤0.01%	10141
2023 Q3	$0	Buy	355 +219	+161%	+$453	﹤0.01%	10171
2023 Q2	$0	Buy	+136	New	+$485	﹤0.01%	10242
2021 Q3	–	Sell	-4	Closed	-$88	–	9930
2021 Q2	$0	Sell	4 -8,370	-100%	-$196K	﹤0.01%	10881
2021 Q1	$243K	Buy	+8,374	New	+$234K	﹤0.01%	4447
2020 Q4	–	Sell	-2,215	Closed	-$35K	–	9267
2020 Q3	$35K	Sell	2,215 -319	-13%	-$5.82K	﹤0.01%	5947
2020 Q2	$50K	Buy	+2,534	New	+$48.4K	﹤0.01%	5499

Simplex Trading's NGM Position: Q2 2024 in Review

Simplex Trading sold out of NGM Biopharmaceuticals, Inc. Common Stock (NGM) in Q2 2024, closing a stake of 28 shares.

Simplex Trading first reported a position in NGM in Q2 2020 and held it in 8 quarters. The position peaked at $243K in Q1 2021. 0 funds tracked by Wall St. Rank hold NGM as of Q2 2024.

Simplex Trading reported no remaining NGM Biopharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Simplex Trading sold 28 NGM Biopharmaceuticals, Inc. Common Stock shares in Q2 2024.
Simplex Trading first reported a position in NGM Biopharmaceuticals, Inc. Common Stock in Q2 2020 and held it in 8 quarters.
Simplex Trading's NGM Biopharmaceuticals, Inc. Common Stock position peaked at $243K in Q1 2021.
0 funds tracked by Wall St. Rank held NGM Biopharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Simplex Trading's 13F filing for Q2 2024, filed 25 Jul 2024.